C0376622||MDR1
C1413882||CYP3A5 genes
C0920028||cytogenetic relapse
C0023473||chronic myeloid leukemia
C0935989||imatinib
C0087111||therapy
C0314627||genes coding
C0935989||imatinib
C0007292||transporters
C0014442||metabolizing enzymes
C0920028||cytogenetic relapse
C0023473||chronic myeloid leukemia
C0023473||chronic myeloid leukemia
C0920028||cytogenetic relapse
C0023473||chronic-phase CML
C0935989||imatinib
C0087111||therapy
C1522577||follow-up
C0752046||single nucleotide polymorphisms
C0752046||single nucleotide polymorphisms
C1285573||genotyped
C0314659||C1236T
C0314659||C3435T
C0314659||G2677T
C0314659||A
C0376622||MDR1 gene
C0314659||A6986G
C1413882||CYP3A5 gene
C3714764||PCR-RFLP method
C1294197||gene sequencing
C0935989||Imatinib
C0872318||LC-MS
C0037813||MS
C0376622||MDR1
C0314659||C1236T
C0920028||cytogenetic relapse
C0376622||MDR1
C0314659||C3435T
C0920028||relapse
C0935989||Imatinib
C0920028||relapse
C0920028||relapse
C0376622||MDR1
C0314659||C3435T
C0920028||relapse
C0314659||C1236T
C0314659||C3435T
C0376622||MDR1 gene
C0920028||cytogenetic relapse
C0376622||MDR1
C0314659||C3435T
C0005516||biomarker
C0920028||cytogenetic relapse
C0023473||chronic myeloid leukemia